在BMAL1/HIF2A异构体调节心肌损伤的昼夜变化

Wei Ruan1,2,3, Tao Li4,3, Jaewoong Lee5,3

  • 1Department of Anesthesiology, Critical Care and Pain Medicine, The University of Texas Health Science Center at Houston, McGovern Medical School, Houston, TX, 77030, USA.

Research square
|March 11, 2024
PubMed
概括

核心昼夜因素BMAL1,与HIF2A合作,控制心脏病发作损伤的每日变化. 针对这种BMAL1/HIF2A-AREG通路提供心脏保护,最有效的时间是该通路的每日最低值.